VentriPoint Diagnostics Ltd. announced it has entered into a global distribution and marketing agreement with ASCEND Cardiovascular. ASCEND Cardiovascular is a leader in offering cutting-edge diagnostic, and imaging technologies and workflows to improve cardiac health care. ASCEND is trusted by AGFA Healthcare, Sectra, Oracle/Cerner, and other major players in the healthcare system.

Its technology stack has been integrated into the workflows of 1,000+ top-ranked healthcare facilities and 600+ health systems, representing a user base of 50,000 who serve millions of heart patients. ASCEND will market and distribute Ventripoint's AI-powered heart-scanning technology, which turns ultrasound images of the heart into MRI-quality heart images. Using AI, and the images from existing ultrasound systems of any brand, Ventripoint creates these MRI-quality heart images at a fraction of the cost and time needed for more traditional heart MRIs.

The global distribution agreement has an initial two-year term, with ASCEND as the official reseller. ASCEND will market and sell the Ventripoint VMS+ system as part of its inclusive solution, as well as integration with ASCEND's cardiovascular IT platform. Ventripoint will be providing support and training to ASCEND on the use and capabilities of the VMS+ during the term of the agreement.

The collaboration between Ventripoint and ASCEND will reduce time to market and overall effort to provide new software solutions to the market. Ventripoint, now commercializing its technology, has won accolades from leading hospitals, and the British Heart Foundation and has drawn international media attention. As the relationship between Ventripoint and ASCEND Cardiovascular continues to evolve, both companies remain committed to driving innovation and excellence in cardiovascular health technology.